ReviewAdvances in therapy2026

Optimizing Extended Adjuvant Endocrine Therapy in Early HR+/HER2- Breast Cancer: The Emerging Role of Genomic Assays and ctDNA MRD.

Yang Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.